These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6256337)

  • 41. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation and inactivation of neocarzinostatin-induced cleavage of DNA.
    Kappen LS; Goldberg IH
    Nucleic Acids Res; 1978 Aug; 5(8):2959-67. PubMed ID: 151264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between DNA strand-scission and DNA synthesis inhibition in HeLa cells treated with neocarzinostatin.
    Beerman TA; Goldberg IH
    Biochim Biophys Acta; 1977 Mar; 475(2):281-93. PubMed ID: 139166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of X-ray induced cytotoxicity by neocarzinostatin in asynchronous and synchronous rat 3Y1 fibroblasts.
    Nakamura K
    Fukuoka Igaku Zasshi; 1993 Aug; 84(8):363-7. PubMed ID: 8375797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effects of neocarzinostatin on superoxide production by monocyte-derived macrophages].
    Ouchi E; Honnda I; Wakui A; Kikuchi K; Ishida N
    Gan No Rinsho; 1986 Apr; 32(4):387-91. PubMed ID: 3012141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
    Ohtsuki K; Ishida N
    Tanpakushitsu Kakusan Koso; 1981 Jun; 26(7):937-49. PubMed ID: 6457319
    [No Abstract]   [Full Text] [Related]  

  • 47. Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese hamster ovary cells: possible release of nonprotein chromophore in cells.
    Miyamoto Y; Maeda H
    Jpn J Cancer Res; 1991 Mar; 82(3):351-6. PubMed ID: 1673676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.
    Kappen LS; Goldberg IH
    Biochemistry; 1980 Oct; 19(21):4786-90. PubMed ID: 6448635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-density dependency in the survival kinetics of neocarzinostatin-treated HeLa cells in monolayer cultures and in spheroids.
    Sasaki T; Kuroda Y; Hoshino F
    J Radiat Res; 1991 Jun; 32(2):202-14. PubMed ID: 1834832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
    Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of ligand-independent cap formation of mouse lymphocytes and Raji cells by neocarzinostatin.
    Yahara I; Iwashita S; Ebina T; Satake M; Ishida N
    Cancer Res; 1979 Nov; 39(11):4687-93. PubMed ID: 159125
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3 cells.
    Iseki S; Mori T
    Cancer Res; 1985 Sep; 45(9):4224-8. PubMed ID: 2992774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune suppression of anti-DNA antibody production using anti-idiotypic antibody-neocarzinostatin conjugates.
    Sasaki T; Koide Y; Yoshigaga K
    Methods Enzymol; 1989; 178():422-32. PubMed ID: 2532290
    [No Abstract]   [Full Text] [Related]  

  • 55. Caffeine-induced recovery from G2 block caused by neocarzinostatin.
    Iseki S; Ebina T; Ishida N
    Gan; 1980 Aug; 71(4):567-71. PubMed ID: 6448762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrasts in the actions of protein antibiotics on deoxyribonucleic acid structure and function.
    Kappen LS; Goldberg IH; Samy TS
    Biochemistry; 1979 Nov; 18(23):5123-7. PubMed ID: 159069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of surface immunoglobulin centeral capping of Daudi cells and cell spreading of HeLa-S3 cells by neocarzinostatin.
    Ebina T; Satake M; Ishida N
    Cancer Res; 1977 Dec; 37(12):4423-9. PubMed ID: 144561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-strand nicking of DNA in vitro by neocarzinostatin and its possible relationship to the mechanism of drug action.
    Beerman TA; Poon R; Goldberg IH
    Biochim Biophys Acta; 1977 Mar; 475(2):294-306. PubMed ID: 139167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding, internalization and the cytotoxicity of monoclonal antibody A7-neocarzinostatin conjugates (A7-NCS) in target cells.
    Kitamura K; Takahashi T; Noguchi A; Takashina K; Tsurumi H; Yamaguchi T
    Tohoku J Exp Med; 1990 Jul; 161(3):199-207. PubMed ID: 2147302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.